These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 34667161)
1. Loss of Numb promotes hepatic progenitor expansion and intrahepatic cholangiocarcinoma by enhancing Notch signaling. Shu Y; Xu Q; Xu Y; Tao Q; Shao M; Cao X; Chen Y; Wu Z; Chen M; Zhou Y; Zhou P; Shi Y; Bu H Cell Death Dis; 2021 Oct; 12(11):966. PubMed ID: 34667161 [TBL] [Abstract][Full Text] [Related]
2. Brahma-Related Gene 1 Inhibition Prevents Liver Fibrosis and Cholangiocarcinoma by Attenuating Progenitor Expansion. Zhou Y; Chen Y; Zhang X; Xu Q; Wu Z; Cao X; Shao M; Shu Y; Lv T; Lu C; Xie M; Wen T; Yang J; Shi Y; Bu H Hepatology; 2021 Aug; 74(2):797-815. PubMed ID: 33650193 [TBL] [Abstract][Full Text] [Related]
3. Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis. Mancarella S; Serino G; Dituri F; Cigliano A; Ribback S; Wang J; Chen X; Calvisi DF; Giannelli G Cell Death Differ; 2020 Aug; 27(8):2330-2343. PubMed ID: 32042099 [TBL] [Abstract][Full Text] [Related]
4. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity. Bi YL; Min M; Shen W; Liu Y Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287 [TBL] [Abstract][Full Text] [Related]
5. Oncogenic potential of IDH1R132C mutant in cholangiocarcinoma development in mice. Ding N; Che L; Li XL; Liu Y; Jiang LJ; Fan B; Tao JY; Chen X; Ji JF World J Gastroenterol; 2016 Feb; 22(6):2071-80. PubMed ID: 26877611 [TBL] [Abstract][Full Text] [Related]
6. Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties. Aoki S; Mizuma M; Takahashi Y; Haji Y; Okada R; Abe T; Karasawa H; Tamai K; Okada T; Morikawa T; Hayashi H; Nakagawa K; Motoi F; Naitoh T; Katayose Y; Unno M BMC Cancer; 2016 Nov; 16(1):854. PubMed ID: 27821106 [TBL] [Abstract][Full Text] [Related]
7. Membrane RRM2-positive cells represent a malignant population with cancer stem cell features in intrahepatic cholangiocarcinoma. Zhao Y; Xue S; Wei D; Zhang J; Zhang N; Mao L; Liu N; Zhao L; Yan J; Wang Y; Cai X; Zhu S; Roessler S; Ji J J Exp Clin Cancer Res; 2024 Sep; 43(1):255. PubMed ID: 39243109 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of Mothers Against Decapentaplegic Homolog 7 Activates the Yes-Associated Protein/NOTCH Cascade and Promotes Liver Carcinogenesis in Mice and Humans. Wang H; Song X; Liao H; Wang P; Zhang Y; Che L; Zhang J; Zhou Y; Cigliano A; Ament C; Superville D; Ribback S; Reeves M; Pes GM; Liang B; Wu H; Evert M; Calvisi DF; Zeng Y; Chen X Hepatology; 2021 Jul; 74(1):248-263. PubMed ID: 33368437 [TBL] [Abstract][Full Text] [Related]
9. MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways. Tiemin P; Fanzheng M; Peng X; Jihua H; Ruipeng S; Yaliang L; Yan W; Junlin X; Qingfu L; Zhefeng H; Jian L; Zihao G; Guoxing L; Boshi S; Ming Z; Qinghui M; Desen L; Lianxin L J Hepatol; 2020 Apr; 72(4):761-773. PubMed ID: 31837357 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of PDZK1IP1, EEF1A2 and RPL41 genes in intrahepatic cholangiocarcinoma. Yang G; Zong H Mol Med Rep; 2016 Jun; 13(6):4786-90. PubMed ID: 27082702 [TBL] [Abstract][Full Text] [Related]
11. Numb modulates intestinal epithelial cells toward goblet cell phenotype by inhibiting the Notch signaling pathway. Yang Y; Zhu R; Bai J; Zhang X; Tian Y; Li X; Peng Z; He Y; Chen L; Ji Q; Chen W; Fang D; Wang R Exp Cell Res; 2011 Jul; 317(11):1640-8. PubMed ID: 21557937 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of the Numb/Notch signaling pathway increases radiation sensitivity in human nasopharyngeal carcinoma cells. Shen ED; Zeng Q Kaohsiung J Med Sci; 2019 Aug; 35(8):474-485. PubMed ID: 31271505 [TBL] [Abstract][Full Text] [Related]
14. Inhibition on Numb/Notch signal pathway enhances radiosensitivity of lung cancer cell line H358. Song SG; Yu HY; Ma YW; Zhang F; Xu XY Tumour Biol; 2016 Oct; 37(10):13705-13719. PubMed ID: 27476167 [TBL] [Abstract][Full Text] [Related]
15. miR-885-5p inhibits proliferation and metastasis by targeting IGF2BP1 and GALNT3 in human intrahepatic cholangiocarcinoma. Lixin S; Wei S; Haibin S; Qingfu L; Tiemin P Mol Carcinog; 2020 Dec; 59(12):1371-1381. PubMed ID: 33052627 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of TBX3 suppresses tumorigenesis in experimental and human cholangiocarcinoma. Deng S; Lu X; Wang X; Liang B; Xu H; Yang D; Cui G; Yonemura A; Paine H; Zhou Y; Zhang Y; Simile MM; Urigo F; Evert M; Calvisi DF; Green BL; Chen X Cell Death Dis; 2024 Jun; 15(6):441. PubMed ID: 38909034 [TBL] [Abstract][Full Text] [Related]
17. Loss of α-1,2-mannosidase MAN1C1 promotes tumorigenesis of intrahepatic cholangiocarcinoma through enhancing CD133-FIP200 interaction. Wei Y; Chen Q; Chen J; Zhou C; Geng S; Shi D; Huang S; Liang Z; Chen X; Ren N; Jiang J Cell Rep; 2023 Dec; 42(12):113588. PubMed ID: 38117655 [TBL] [Abstract][Full Text] [Related]
18. NUMB is a break of WNT-Notch signaling cycle. Katoh M; Katoh M Int J Mol Med; 2006 Sep; 18(3):517-21. PubMed ID: 16865239 [TBL] [Abstract][Full Text] [Related]
19. ST3GAL1 Promotes Malignant Phenotypes in Intrahepatic Cholangiocarcinoma. Chen F; Gao K; Li Y; Li Y; Wu Y; Dong L; Yang Z; Shi J; Guo K; Gao Q; Lu H; Zhang S Mol Cell Proteomics; 2024 Sep; 23(9):100821. PubMed ID: 39069074 [TBL] [Abstract][Full Text] [Related]
20. The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma. Di Matteo S; Nevi L; Costantini D; Overi D; Carpino G; Safarikia S; Giulitti F; Napoletano C; Manzi E; De Rose AM; Melandro F; Bragazzi M; Berloco PB; Giuliante F; Grazi G; Giorgi A; Cardinale V; Adorini L; Gaudio E; Alvaro D PLoS One; 2019; 14(1):e0210077. PubMed ID: 30677052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]